RepliCel Life Sciences (TSE:RP) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
RepliCel Life Sciences has rescheduled its annual meeting to January 16, 2025, where shareholders will vote on the sale of assets and delisting from the TSX Venture Exchange. The company also announced the resignation of board member Jamie Mackay, who played a crucial role in maintaining company operations during challenging times.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.